Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1907)	4/3/2003 6:17:17 PM
From: scaram(o)uche	Respond to of 2243

keep it coming, please. (eom)

To: Icebrg who wrote (1907)	4/9/2003 6:40:21 PM
From: Icebrg	Read Replies (1) \| Respond to of 2243

>> Spectrum Pharmaceuticals (SPPI)>> Things are more or less going back to normal. I.e. the share price is falling back again. Perhaps not so unexpected as there hasn't been any news. Somewhat unexpected was however that the company today informed us that they have received a de-listing notice from Nasdaq's small capital market. In the end it will most probably be the success or lack thereof for Satraplatin that will decide the company's fate. (As well as the financial status of its shareholders). Being off the Nasdaq lists will reduce the comfort while we wait for the results. The company has said that they intend to appeal. I don't have any experience in this area and have no idea if this should be treated as a serious matter or just a nuisance. Time will tell. Erik